Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nebulized Dexmedetomidine for Lung Function in COPD
NCT06207331Terminated
- Sponsor
- The 2nd Affiliated Hospital of Chongqing Medical University
- Start
- Oct 2023
- Primary completion
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of dexmedetomidine in chronic obstructive pulmonary disease (COPD) (3 arms), sponsored by The 2nd Affiliated Hospital of Chongqing Medical University. Primary endpoint: Forced Vital Capacity. Started Oct 2023; status: terminated.
02
Drugs
dexmedetomidine
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT06207331.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06207331.